Zobrazeno 1 - 10
of 184
pro vyhledávání: '"V, Von Fliedner"'
Autor:
S, Marazzi, S, Blum, R, Hartmann, D, Gundersen, M, Schreyer, S, Argraves, V, von Fliedner, R, Pytela, C, Rüegg
Publikováno v:
The Journal of Immunology. 161:138-147
We have recently cloned the human homologue of the murine pT49 cDNA (hpT49h), a transcript encoding a protein homologous to the β- and γ-chains of fibrinogen. Here, we report the identification of the hpT49h gene product using mAbs generated agains
Autor:
Andreas Tobler, Emanuel Jacky, V. von Fliedner, L. Tschopp, André Tichelli, Cavalli Franco, J. Gmuer, M. Fopp, Alois Gratwohl, Martin F. Fey, M. Bacchi, L. Schmid
Publikováno v:
Annals of Oncology. 8:251-257
Background: Intensification of post-remission therapy improves the cure rate of acute myeloid leukemia (AML) but is often accompanied by unacceptable toxicity. From 1985 to 1992 the Swiss Group for Clinical Cancer Research (SAKK) performed a randomiz
Autor:
L Perey, Ferdy J. Lejeune, V. von Fliedner, Fedor Bachmann, JPh Grob, Ph. Schneider, P. Vuichard, J. Bauer, Nicolas Ketterer, Serge Leyvraz
Publikováno v:
British Journal of Cancer
Dose intensity may be an important determinant of the outcome in cancer chemotherapy, but is often limited by cumulative haematological toxicity. The availability of haematopoietic growth factors such as granulocyte colony-stimulating factor (G-CSF)
Autor:
J‐P. Grob, Martin F. Fey, A. Pedrazzini, M. Wernli, Emanuel Jacky, L. Schmid, V. von Fliedner, Andreas Tobler, André Tichelli, M. Fopp, G. Brun del Re, Gmür J, H‐J. Senn, Alois Gratwohl, B. Chaputs
Publikováno v:
British Journal of Haematology. 87:39-43
Maintenance chemotherapy for up to 3 years is traditionally given to patients with acute lymphoblastic leukaemia (ALL) achieving complete remission. We questioned the value of such maintenance therapy in adult patients treated with intensive inductio
Publikováno v:
Annals of Oncology. 3:11-16
Publikováno v:
Clinical and Experimental Immunology. 79:105-108
SUMMARYHuman tumour-infiltrating lymphocytes (TIL) were prepared by enzyme digestion from a series of different tumours and were purified on a fluorescence-activated cell sorter (FACS II) according to their CD4+ and CD8+ phenotype. CD4+ and CD8+ TIL
Publikováno v:
Blood purification. 18(2)
Background: Much research has been devoted to the determination of acute leukocyte activation as well as acute cytokines production during and after blood hemodialysis membrane interaction. In contrast, few studies deal with chronic immunological eva
Autor:
M, Fopp, M F, Fey, M, Bacchi, F, Cavalli, J, Gmuer, E, Jacky, L, Schmid, A, Tichelli, A, Tobler, L, Tschopp, V, Von Fliedner, A, Gratwohl
Publikováno v:
Annals of oncology : official journal of the European Society for Medical Oncology. 8(3)
Intensification of post-remission therapy improves the cure rate of acute myeloid leukemia (AML) but is often accompanied by unacceptable toxicity. From 1985 to 1992 the Swiss Group for Clinical Cancer Research (SAKK) performed a randomized phase III
Publikováno v:
Therapeutic immunology. 1(3)
One approach to adoptive cancer immunotherapy is based on the use of bispecific monoclonal antibodies (mAb) capable to redirect ex vivo generated cytolytic T lymphocytes (CTL) onto tumour cells. The efficiency of the CD28 T-cell activation pathway to
Autor:
V Von Fliedner, Marie-Denise Schaller, Michele Markert, T Laurent, M C Tagan, René Chioléro, Claude Perret, François Feihl
Publikováno v:
American journal of respiratory and critical care medicine. 149(6)
The accumulation of granulocytes in the pulmonary microvasculature is generally thought a cardinal event in the pathology of adult respiratory distress syndrome (ARDS). However, the mechanism by which granulocytes are sequestered in the pulmonary vas